Healthcare -
Biotechnology - NASDAQ - US
$ 7.58
-2.57 %
$ 162 M
Market Cap
-1.53
P/E
ENTA - CASH & EQUIVALENTS
Cash & Equivalents ENTA - Enanta Pharmaceuticals, Inc.
37.2 M
LAST VALUE
-8.00%
2 YEAR CAGR
-6.18%
5 YEAR CAGR
1.95%
10 YEAR CAGR